迪马匹莫德

迪马匹莫德（CAS 444606-18-2）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

• Dilmapimod has been used in trials studying the treatment and diagnostic of Nerve Trauma, Inflammation, Pain, Neuropathic, Arthritis, Rheumatoid, and Coronary Heart Disease, among others.
• Dilmapimod reduces the levels of proinflammatory cytokines and chemokines and reduce cellular infiltration to sites of inflammation, thereby reducing local damage. In diseases such as RA and IBD, TNFα blockade through either anti-TNFα antibodies or use of soluble TNFα receptors. Inhibition of p38α offers significant inhibition of TNFα, and cytokines such as IL-1β and IL-6, which offer additional therapeutic efficacy.

同义词与商品名

Dilmapimod; 444606-18-2; SB-681323; Q3238VQW0N; SB681323; DTXSID101318338; dilmapimodum; GW681323; RefChem:587981; DTXCID401748150; Dilmapimod [USAN:INN]; GW 681323; UNII-Q3238VQW0N; SB 681323; GSK 681323; SB-681323; GW 681323

公开数据库对它的描述

Dilmapimod · CAS 444606-18-2 · C23H19F3N4O3. UNII Q3238VQW0N.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。